Crinetics Pharmaceuticals (CRNX) Other Gross PP&E Adjustments (2017 - 2025)
Historic Other Gross PP&E Adjustments for Crinetics Pharmaceuticals (CRNX) over the last 9 years, with Q3 2025 value amounting to -$19.7 million.
- Crinetics Pharmaceuticals' Other Gross PP&E Adjustments rose 2286.91% to -$19.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.7 million, marking a year-over-year increase of 2286.91%. This contributed to the annual value of -$41.8 million for FY2024, which is 235.94% up from last year.
- Crinetics Pharmaceuticals' Other Gross PP&E Adjustments amounted to -$19.7 million in Q3 2025, which was up 2286.91% from -$17.6 million recorded in Q2 2025.
- Crinetics Pharmaceuticals' Other Gross PP&E Adjustments' 5-year high stood at $6.6 million during Q2 2023, with a 5-year trough of -$42.8 million in Q4 2023.
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was -$2.1 million (2022), whereas its average is -$11.9 million.
- In the last 5 years, Crinetics Pharmaceuticals' Other Gross PP&E Adjustments surged by 36051.23% in 2022 and then tumbled by 196797.1% in 2023.
- Crinetics Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$1.5 million in 2021, then plummeted by 39.3% to -$2.1 million in 2022, then tumbled by 1967.97% to -$42.8 million in 2023, then rose by 2.36% to -$41.8 million in 2024, then surged by 52.8% to -$19.7 million in 2025.
- Its last three reported values are -$19.7 million in Q3 2025, -$17.6 million for Q2 2025, and -$21.4 million during Q1 2025.